Ming Tan Selected Research

Blood Group Antigens (Blood Groups)

1/2022	Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses.
1/2022	Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors.
7/2021	Characterization of Functional Components in Bovine Colostrum That Inhibit Norovirus Capsid Protruding Domains Interacting with HBGA Ligands.
1/2021	Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study.
6/2020	Epidemiology and HBGA-susceptibility investigation of a G9P[8] rotavirus outbreak in a school in Lechang, China.
1/2019	Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths.
1/2018	Quantifying the binding stoichiometry and affinity of histo-blood group antigen oligosaccharides for human noroviruses.
7/2015	Tulane virus recognizes sialic acids as cellular receptors.
7/2015	A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface.
2/2015	Strain-specific interaction of a GII.10 Norovirus with HBGAs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Tan Research Topics

Disease

65	Neoplasms (Cancer) 11/2019 - 05/2002
35	Infections 01/2022 - 02/2003
33	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2002
16	Gastroenteritis 01/2022 - 06/2005
13	Neoplasm Metastasis (Metastasis) 06/2021 - 11/2004
8	Diarrhea 01/2021 - 05/2012
7	Nasopharyngeal Carcinoma 11/2019 - 12/2007
7	Leukemia 07/2019 - 08/2003
7	Pain (Aches) 06/2014 - 03/2009
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2009
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2019 - 08/2003
5	Inflammation (Inflammations) 10/2017 - 08/2007
5	Carcinogenesis 01/2017 - 08/2009
4	Human Influenza (Influenza) 01/2022 - 12/2004
4	Caliciviridae Infections 07/2015 - 06/2005
4	Hyperalgesia 10/2011 - 08/2007
3	Chlamydia Infections 01/2021 - 04/2009
3	Triple Negative Breast Neoplasms 02/2020 - 01/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 02/2004
3	Thrombosis (Thrombus) 06/2018 - 01/2016
3	Squamous Cell Carcinoma of Head and Neck 03/2015 - 04/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 09/2014 - 09/2008
3	Knee Osteoarthritis 06/2014 - 03/2009
2	COVID-19 10/2021 - 01/2021
2	Febrile Neutropenia 10/2021 - 02/2003
2	Neuralgia (Stump Neuralgia) 11/2020 - 09/2011
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2019 - 11/2014
2	Decapitation 10/2018 - 04/2018
2	Lymphatic Metastasis 04/2016 - 02/2015

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
21	Blood Group Antigens (Blood Groups)IBA 01/2022 - 06/2005
14	VaccinesIBA 01/2022 - 02/2008
12	Pharmaceutical PreparationsIBA 06/2017 - 09/2002
11	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2008
10	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 02/2009
8	MicroRNAs (MicroRNA)IBA 11/2020 - 07/2010
8	Glucose (Dextrose)FDA LinkGeneric 08/2017 - 01/2011
7	Polysaccharides (Glycans)IBA 01/2021 - 10/2017
6	salicylhydroxamic acid (SHAM)IBA 01/2016 - 06/2010
5	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2008
5	Trastuzumab (Herceptin)FDA Link 02/2021 - 08/2004
5	LigandsIBA 01/2021 - 03/2014
5	RNA (Ribonucleic Acid)IBA 02/2017 - 08/2002
5	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 02/2003
5	Peptides (Polypeptides)IBA 03/2015 - 04/2006
4	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2004
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2003
4	Lactate Dehydrogenase 5IBA 03/2019 - 02/2010
4	Immune Sera (Antisera)IBA 11/2018 - 01/2014
4	Phosphotransferases (Kinase)IBA 01/2018 - 02/2006
4	Docetaxel (Taxotere)FDA Link 01/2017 - 12/2009
4	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 08/2002
3	Long Noncoding RNAIBA 01/2022 - 01/2014
3	Hormones (Hormone)IBA 10/2021 - 05/2008
3	Rotavirus VaccinesIBA 01/2021 - 01/2019
3	Therapeutic UsesIBA 01/2021 - 05/2012
3	Protein Isoforms (Isoforms)IBA 02/2020 - 09/2014
3	Lactic Acid (Lactate)FDA LinkGeneric 03/2019 - 01/2015
3	Pyruvic Acid (Pyruvate)IBA 03/2019 - 01/2015
3	AntigensIBA 01/2019 - 11/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 11/2004
3	Drug CombinationsIBA 06/2017 - 07/2008
3	Biological ProductsIBA 01/2016 - 06/2005
3	Small Interfering RNA (siRNA)IBA 01/2015 - 05/2009
3	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2013 - 03/2005
3	Etoposide (VP 16)FDA LinkGeneric 04/2013 - 03/2005
3	Cisplatin (Platino)FDA LinkGeneric 04/2012 - 12/2009
3	Freund's AdjuvantIBA 11/2011 - 08/2007
2	InterferonsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 10/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 10/2011
2	Sialic AcidsIBA 12/2021 - 07/2015
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2021 - 05/2012
2	human ERBB2 proteinIBA 10/2021 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 06/2021 - 01/2016
2	pertuzumabIBA 02/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2021 - 08/2012
2	Estrogens (Estrogen)FDA Link 02/2020 - 01/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 11/2014
2	HomoharringtonineIBA 09/2019 - 07/2019
2	Arsenic Trioxide (Trisenox)FDA Link 09/2019 - 07/2019
2	Adenosine Triphosphate (ATP)IBA 08/2019 - 01/2011
2	Histone Deacetylase InhibitorsIBA 01/2019 - 04/2013
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2014
2	Lovastatin (Mevacor)FDA LinkGeneric 10/2018 - 04/2018
2	Cyclin D1IBA 01/2018 - 01/2014
2	Thrombin FDA Link 06/2017 - 01/2016
2	ParaffinIBA 02/2017 - 06/2011
2	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016 - 01/2016
2	Tyrosine (L-Tyrosine)FDA Link 05/2016 - 05/2002
2	MTOR InhibitorsIBA 02/2016 - 10/2004
2	CarbohydratesIBA 07/2015 - 08/2010
2	NF-kappa B (NF-kB)IBA 01/2015 - 01/2014

Therapy/Procedure

30	Therapeutics 10/2021 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2019 - 09/2008
5	Electroacupuncture 11/2011 - 08/2007
3	Lasers (Laser) 07/2019 - 03/2009
3	Induction Chemotherapy 04/2012 - 12/2009